IRIS Accounts Production v25.1.4.42 08996353 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089963532023-09-30089963532024-09-30089963532023-10-012024-09-30089963532023-04-30089963532023-05-012023-09-30089963532023-09-3008996353ns15:EnglandWales2023-10-012024-09-3008996353ns14:PoundSterling2023-10-012024-09-3008996353ns10:Director12023-10-012024-09-3008996353ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3008996353ns10:SmallEntities2023-10-012024-09-3008996353ns10:AuditExemptWithAccountantsReport2023-10-012024-09-3008996353ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3008996353ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3008996353ns10:FullAccounts2023-10-012024-09-300899635312023-10-012024-09-3008996353ns10:Director22023-10-012024-09-3008996353ns10:Director32023-10-012024-09-3008996353ns10:Director42023-10-012024-09-3008996353ns10:Director52023-10-012024-09-3008996353ns10:RegisteredOffice2023-10-012024-09-3008996353ns5:CurrentFinancialInstruments2024-09-3008996353ns5:CurrentFinancialInstruments2023-09-3008996353ns5:Non-currentFinancialInstruments2024-09-3008996353ns5:Non-currentFinancialInstruments2023-09-3008996353ns5:ShareCapital2024-09-3008996353ns5:ShareCapital2023-09-3008996353ns5:SharePremium2024-09-3008996353ns5:SharePremium2023-09-3008996353ns5:RetainedEarningsAccumulatedLosses2024-09-3008996353ns5:RetainedEarningsAccumulatedLosses2023-09-3008996353ns5:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3008996353ns5:PatentsTrademarksLicencesConcessionsSimilar2023-10-012024-09-3008996353ns5:IntangibleAssetsOtherThanGoodwill2023-09-3008996353ns5:IntangibleAssetsOtherThanGoodwill2024-09-3008996353ns5:IntangibleAssetsOtherThanGoodwill2023-09-3008996353ns5:PlantMachinery2023-09-3008996353ns5:PlantMachinery2023-10-012024-09-3008996353ns5:PlantMachinery2024-09-3008996353ns5:PlantMachinery2023-09-3008996353ns5:CostValuation2023-09-3008996353ns5:RevaluationsIncreaseDecreaseInInvestments2024-09-3008996353ns5:CostValuation2024-09-3008996353ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3008996353ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3008996353ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-09-3008996353ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-09-30
REGISTERED NUMBER: 08996353 (England and Wales)

























Unaudited Financial Statements

for the Year Ended 30 September 2024

for

Ingenious Laboratories Limited

Ingenious Laboratories Limited (Registered number: 08996353)






Contents of the Financial Statements
for the year ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 7

Ingenious Laboratories Limited

Company Information
for the year ended 30 September 2024







DIRECTORS: P S Ghatora
D M Hyland
Ms L Zhou
P Crowe
S K Ghatora





REGISTERED OFFICE: 2 Maple Court
Davenport Street
Macclesfield
Cheshire
SK10 1JE





REGISTERED NUMBER: 08996353 (England and Wales)





ACCOUNTANTS: Bennett Brooks & Co Limited
Chartered Accountants
St George's Court
Winnington Avenue
Northwich
Cheshire
CW8 4EE

Ingenious Laboratories Limited (Registered number: 08996353)

Balance Sheet
30 September 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 7,708 8,689
Tangible assets 5 5,838 4,331
Investments 6 83 87
13,629 13,107

CURRENT ASSETS
Stocks 261,531 254,554
Debtors 7 333,560 298,404
Cash at bank 466,543 421,074
1,061,634 974,032
CREDITORS
Amounts falling due within one year 8 201,107 178,395
NET CURRENT ASSETS 860,527 795,637
TOTAL ASSETS LESS CURRENT
LIABILITIES

874,156

808,744

CREDITORS
Amounts falling due after more than one year 9 247,949 259,135
NET ASSETS 626,207 549,609

CAPITAL AND RESERVES
Called up share capital 10 183 183
Share premium 560,620 560,620
Retained earnings 65,404 (11,194 )
626,207 549,609

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 June 2025 and were signed on its behalf by:



P S Ghatora - Director


Ingenious Laboratories Limited (Registered number: 08996353)

Notes to the Financial Statements
for the year ended 30 September 2024

1. STATUTORY INFORMATION

Ingenious Laboratories Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Computer equipment - 25% straight line

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Short term debtors and creditors
Short term debtors and creditors with no stated interest rate are recorded at transaction price. Any losses arising from impairment are recognised in the income statement.

Share capital
Ordinary, Ordinary A and Ordinary B shares are classed as equity.

Cash and cash equivalents
Cash and cash equivalents includes cash in hand and cash held with banks.

Ingenious Laboratories Limited (Registered number: 08996353)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

2. ACCOUNTING POLICIES - continued

Distributions to equity holders
Dividends are recognised as a liability in the financial statements in the period in which the dividends are approved by the company's shareholders. These amounts are recognised in the statement of changes in equity.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 October 2023
and 30 September 2024 9,811
AMORTISATION
At 1 October 2023 1,122
Charge for year 981
At 30 September 2024 2,103
NET BOOK VALUE
At 30 September 2024 7,708
At 30 September 2023 8,689

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 7,924
Additions 3,471
At 30 September 2024 11,395
DEPRECIATION
At 1 October 2023 3,593
Charge for year 1,964
At 30 September 2024 5,557
NET BOOK VALUE
At 30 September 2024 5,838
At 30 September 2023 4,331

Ingenious Laboratories Limited (Registered number: 08996353)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 October 2023 87
Revaluations (4 )
At 30 September 2024 83
NET BOOK VALUE
At 30 September 2024 83
At 30 September 2023 87

Cost or valuation at 30 September 2024 is represented by:

Other
investments
£   
Cost 83

7. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 3,250 15,354
Amounts owed by group undertakings 144,449 160,096
Other debtors 138,487 119,165
286,186 294,615

Amounts falling due after more than one year:
Other debtors 47,374 3,789

Aggregate amounts 333,560 298,404

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 9,795 9,420
Trade creditors 51,639 114,771
Taxation and social security 132,823 45,906
Other creditors 6,850 8,298
201,107 178,395

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 6,872 18,058
Other creditors 241,077 241,077
247,949 259,135

Ingenious Laboratories Limited (Registered number: 08996353)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

10. CALLED UP SHARE CAPITAL

Allocated, issues and fully paid:
Number: Class Nominal 2024 2023
value: £    £   
8,654 Ordinary £0.01 87 87
4,800 Ordinary A £0.01 48 48
4,800 Ordinary B £0.01 48 48
183 183

11. RELATED PARTY DISCLOSURES

Entities with significant influence.

Included within other loans falling due after 1 year is a loan facility for £116,077 (2023: £146,077) with an entity with a participating interest in the company. The loan facility is reviewed every 13 months and is accruing no interest.

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Ingenious Laboratories Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ingenious Laboratories Limited for the year ended 30 September 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Ingenious Laboratories Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Ingenious Laboratories Limited and state those matters that we have agreed to state to the Board of Directors of Ingenious Laboratories Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ingenious Laboratories Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Ingenious Laboratories Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Ingenious Laboratories Limited. You consider that Ingenious Laboratories Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Ingenious Laboratories Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Bennett Brooks & Co Limited
Chartered Accountants
St George's Court
Winnington Avenue
Northwich
Cheshire
CW8 4EE


25 June 2025